The promise, and risk, of a new Alzheimer’s drug
Apple News Today
00:00
The Health Impact of Ultra-Processed Foods
The drug will only be available for people with mild cognitive impairment or early-stage Alzheimer's. Some doctors and researchers are skeptical of the drug because it also has serious risks. The FDA is requiring its strongest warning label on the packaging. Three deaths were linked to the clinical trials.
Transcript
Play full episode
